sq-11725 has been researched along with indocyanine green in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bolognesi, M; Caregaro, L; Finucci, GF; Gatta, A; Merkel, C; Rondana, M; Ruol, A; Sacerdoti, D | 1 |
Amodio, P; Angeli, P; Bolognesi, M; Buonamico, P; Gatta, A; Merkel, C; Micotti, L; Sacerdoti, D; Sticca, A | 1 |
3 other study(ies) available for sq-11725 and indocyanine green
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis.
Topics: Adult; Heart Rate; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Middle Aged; Nadolol | 1988 |
Effect of chronic treatment with nadolol plus isosorbide mononitrate on liver blood flow and liver metabolic activity in cirrhosis.
Topics: Adrenergic beta-Antagonists; Coloring Agents; Delayed-Action Preparations; Drug Therapy, Combination; Female; Hepatic Veins; Humans; Indocyanine Green; Isosorbide Dinitrate; Liver; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Nadolol; Nitric Oxide Donors; Venous Pressure | 1999 |